S. Kesten - Concepedia

Author

S. Kesten

Warde Medical Laboratory

Also Known As

S. J. KESTEN, S. J. Kesten, S. KESTEN, S. Kesten, Simone Kesten, Stephen J. Kesten

Publications

465

Citations

H-Index

Concepts

All Affiliations

Warde Medical Laboratory

About

S. Kesten is an author at Warde Medical Laboratory specializing in pharmacology, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	311
2	Natural Sciences	5	5	311
3	Biochemistry	4	4	272
4	Engineering	2	2	41
5	Biomolecular Engineering	2	2	208

S. Kesten

Publications

438

Citations

H-Index

Page 1

	Year	Citations
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith, ACS Medicinal Chemistry Letters Pharmaceutical ScienceMolecular PainPharmacotherapyPharmaceutical ChemistryRat Model	2010	196
Antimalarial drugs. 64. Synthesis and antimalarial properties of 1-imino derivatives of 7-chloro-3-substituted-3,4-dihydro-1,9(2H,10H)-acridinediones and related structures S. Kesten, M J Degnan, J. Hung, Journal of Medicinal Chemistry	1992	55
Antimalarial drugs. 60. Synthesis, antimalarial activity, and quantitative structure-activity relationships of tebuquine and a series of related 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N.omega.-oxides Leslie M. Werbel, P. Dan Cook, Edward F. Elslager, Journal of Medicinal Chemistry Combinatorial ChemistryPharmaceutical ScienceBioorganic ChemistryAntiparasitic AgentMalaria	1986	52
Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents Jagadish C. Sircar, Thomas Capiris, S. Kesten, Journal of Medicinal Chemistry Bioorganic ChemistryAntiparasitic AgentAltmetric Attention ScorePharmacotherapyNew Series	1981	39
Antimalarial drugs. 61. Synthesis and antimalarial effects of 4-[(7-chloro-4-quinolinyl)amino]-2-[(diethylamino)methyl]-6-alkylphenols and their N.omega.-oxides S. Kesten, Judith L. Johnson, Leslie M. Werbel Journal of Medicinal Chemistry	1987	31
A novel modification of the Ritter reaction using trimethylsilyl cyanide H.G. Chen, O. P. Goel, S. Kesten, Tetrahedron Letters Chemical EngineeringRitter ReactionEngineeringOrganic ChemistryOrganometallic Catalysis	1996	29
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-l-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H-imidazole-5-carboxylic acid (CI-996) Ila Sircar, John C. Hodges, John Quin, Journal of Medicinal Chemistry Compound 18Vivo Rat ModelPeptide SciencePharmacotherapyPharmaceutical Chemistry	1993	12
Reactions of 2<i>H</i>‐3,1‐benzoxazine‐2,4‐(1<i>H</i>)dione (isatoic anhydride) with anions of 1,4‐dihydro‐5<i>H</i>‐pyrazol‐5‐ones: Synthesis of pyrazolo[5,1‐<i>b</i>]quinazolin‐9‐ones Jagadish C. Sircar, Thomas Capiris, S. Kesten Journal of Heterocyclic Chemistry Diversity Oriented SynthesisBioorganic ChemistryEngineeringHeterocyclicAnion 2B	1981	12
A practical and scalable synthesis of SR 142801, a tachykinin NK3 antagonist Huai.G. Chen, Fu‐Zon Chung, O. P. Goel, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryNatural Product SynthesisBiochemistryMedicineSr 142801	1997	12

Page 1